Skip to main content
. 2020 Nov 30;20:514. doi: 10.1186/s12877-020-01921-0

Table 3.

Complication and Treatment during hospitalizationin the Discharged and Death Groups

Total(n = 141) Discharged(n = 123) Death(n = 18) Ρ value
Complication-no.(%)
 Arrhythmia 39(27.7) 32(26.0) 7(38.9) 0.391
 ARDS 17(12.1) 7(5.7) 10(55.6) 0.000
 Shock 8(5.7) 0(0) 8(44.4) 0.000
Treatment-no.(%)
 Antiviral therapy 131(92.9) 116(92.8) 15(93.8) 1.000
 Oseltamivir 18(12.8) 17(13.8) 1(5.6) 0.546
 Arbidol 129(91.5) 113(91.9) 16(88.9) 1.000
 Oseltamivir+Arbidol 16(11.3) 15(12.2) 1(5.6) 0.666
 Antibiotics 108(76.6) 90(73.2) 18(100.0) 0.027
 Antifungal 6(4.3) 3(2.4) 3(16.7) 0.028
 Glucocorticoid 29(20.6) 16(13.0) 13(72.2) 0.000
 Immunoglobulin transfusion 15(10.6) 8(6.5) 7(38.9) 0.000
 Blood transfusion 8(5.7) 5(4.1) 3(16.7) 0.107
NIV-no.(%) 15(10.6) 4(3.3) 11(61.1) 0.000
IMV-no.(%) 6(4.3) 1(0.8) 5(27.8) 0.000

Ρ value: comparison between Discharged and Death groups. ARDS acute respiratory distress syndrome, NIV noninvasive ventilation, IMV invasive mechanical ventilation